Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis

K. Gowin, H. Kosiorek, A. Dueck, J. Mascarenhas, R. Hoffman, C. Reeder, J. Camoriano, R. Tibes, K. Gano, J. Palmer, Ruben Mesa

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint Dive into the research topics of 'Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences